N-terminal pro-brain natriuretic peptide and resistance to chronic therapy with 75 mg acetylsalicylic acid assessed by point-of-care test - prospective single center study.
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker

Bieganski Hospital, Lodz (Poland)
7 More presentations in this session
Doctor J. Sousa (Funchal, PT)
Doctor D. Cortez (Sacramento, US)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
